{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:14:50Z","timestamp":1791234890120,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.amjmed.2014.03.019","type":"journal-article","created":{"date-parts":[[2014,3,26]],"date-time":"2014-03-26T09:07:59Z","timestamp":1395824879000},"page":"664-668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Randomized Controlled Trial of Sildenafil for Preventing Recurrent Ischemic Priapism in Sickle Cell Disease"],"prefix":"10.1016","volume":"127","author":[{"given":"Arthur L.","family":"Burnett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzoma A.","family":"Anele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene N.","family":"Trueheart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Strouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Casella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 5","key":"10.1016\/j.amjmed.2014.03.019_bib1","first-page":"S39","article-title":"Report of the American Foundation for Urologic Disease (AFUD) Thought Leader Panel for evaluation and treatment of priapism","volume":"13","author":"Berger","year":"2001","journal-title":"Int J Impot Res"},{"issue":"4 Pt 1","key":"10.1016\/j.amjmed.2014.03.019_bib2","first-page":"1318","article-title":"American Urological Association guideline on the management of priapism","volume":"170","author":"Montague","year":"2003","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.amjmed.2014.03.019_bib3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1464-4096.2001.01510.x","article-title":"Low-flow priapism: risk factors for erectile dysfunction","volume":"89","author":"El-Bahnasawy","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.amjmed.2014.03.019_bib4","first-page":"65","article-title":"Priapism associated with the sickle cell hemoglobinopathies: prevalence, natural history and sequelae","volume":"145","author":"Fowler","year":"1991","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.amjmed.2014.03.019_bib5","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/archinte.1980.00330220022011","article-title":"Priapism and impotence in homozygous sickle cell disease","volume":"140","author":"Emond","year":"1980","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2014.03.019_bib6","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1046\/j.1464-410X.2002.03022.x","article-title":"Priapism in sickle-cell disease; incidence, risk factors and complications - an international multicentre study","volume":"90","author":"Adeyoju","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.amjmed.2014.03.019_bib7","first-page":"79","article-title":"New insights into the pathophysiology of sickle cell disease-associated priapism","volume":"9","author":"Bivalacqua","year":"2012","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.amjmed.2014.03.019_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02938325","article-title":"Molecular science of priapism","volume":"4","author":"Burnett","year":"2007","journal-title":"Curr Sex Health Rep"},{"key":"10.1016\/j.amjmed.2014.03.019_bib9","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0407183102","article-title":"Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism","volume":"102","author":"Champion","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.amjmed.2014.03.019_bib10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11934-006-0061-6","article-title":"Priapism: new concepts in the pathophysiology and new treatment strategies","volume":"7","author":"Bivalacqua","year":"2006","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.amjmed.2014.03.019_bib11","first-page":"1077","article-title":"Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism","volume":"3","author":"Burnett","year":"2006","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.amjmed.2014.03.019_bib12","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.urology.2005.11.045","article-title":"Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism","volume":"67","author":"Burnett","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.amjmed.2014.03.019_bib13","series-title":"Product Information: Viagra\u00ae, Sildenafil Citrate","year":"2010"},{"key":"10.1016\/j.amjmed.2014.03.019_bib14","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.eururo.2013.01.012","article-title":"Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis","volume":"63","author":"Yuan","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.amjmed.2014.03.019_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ucl.2011.02.005","article-title":"Priapism: new concepts in medical and surgical management","volume":"38","author":"Burnett","year":"2011","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.amjmed.2014.03.019_bib16","first-page":"104","article-title":"Sexual health outcomes improvement in sickle cell disease: a matter of health policy?","volume":"9","author":"Burnett","year":"2012","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.amjmed.2014.03.019_bib17","first-page":"1244","article-title":"Sickle cell disease status and outcomes of African-American men presenting with priapism","volume":"5","author":"Bennett","year":"2008","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.amjmed.2014.03.019_bib18","first-page":"375","article-title":"A\u00a0prospective diary study of stuttering priapism in adolescents and young men with sickle cell anemia: report of an international randomized control trial\u2013the priapism in sickle cell study","volume":"32","author":"Olujohungbe","year":"2011","journal-title":"J\u00a0Androl"},{"key":"10.1016\/j.amjmed.2014.03.019_bib19","doi-asserted-by":"crossref","first-page":"e68028","DOI":"10.1371\/journal.pone.0068028","article-title":"Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative\/nitrosative stress","volume":"8","author":"Bivalacqua","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.amjmed.2014.03.019_bib20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1124\/mol.104.010678","article-title":"Erection capability is potentiated by long-term sildenafil treatment: role of blood flow-induced endothelial nitric-oxide synthase phosphorylation","volume":"68","author":"Musicki","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.amjmed.2014.03.019_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1096\/fj.13-228817","article-title":"Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism","volume":"28","author":"Lagoda","year":"2014","journal-title":"FASEB J"},{"key":"10.1016\/j.amjmed.2014.03.019_bib22","first-page":"1980","article-title":"Targeting NADPH oxidase decreases oxidative stress in the transgenic sickle cell mouse penis","volume":"9","author":"Musicki","year":"2012","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.amjmed.2014.03.019_bib23","first-page":"424","article-title":"Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penis","volume":"11","author":"Musicki","year":"2014","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.amjmed.2014.03.019_bib24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/ijir.2010.27","article-title":"Experimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue","volume":"22","author":"Kanika","year":"2010","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.amjmed.2014.03.019_bib25","first-page":"762","article-title":"Molecular analysis of erection regulatory factors in sickle cell disease associated priapism in the human penis","volume":"189","author":"Lagoda","year":"2013","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.amjmed.2014.03.019_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/1742395307081505","article-title":"The physical, social and psychological impact of priapism on adult males with sickle cell disorder","volume":"3","author":"Addis","year":"2007","journal-title":"Chronic Illn"},{"key":"10.1016\/j.amjmed.2014.03.019_bib27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jclinepi.2013.08.015","article-title":"Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects","volume":"67","author":"McCambridge","year":"2014","journal-title":"J\u00a0Clin Epidemiol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934314002733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934314002733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:02:56Z","timestamp":1757581376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934314002733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0002934314002733"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2014.03.019","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized Controlled Trial of Sildenafil for Preventing Recurrent Ischemic Priapism in Sickle Cell Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2014.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}